Thomas Catinazzo - 28 Oct 2026 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
30 Oct 2026, 16:14:53 UTC
Prior SEC filing
08 Oct 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Soo-Yeun Lim, as Attorney-in-Fact
Filing notes and source

Key filing fact

Thomas Catinazzo filed Form 4 for Relay Therapeutics, Inc. (RLAY) on 30 Oct 2026.

Key facts

  • This page summarizes Thomas Catinazzo's Form 4 filing for Relay Therapeutics, Inc. (RLAY).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 30 Oct 2026, 16:14.

Change

  • Previous filing in this sequence was filed on 08 Oct 2026.
  • Current net transaction value: -$27,353.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001818261 Primary reporting owner

Catinazzo Thomas

Relationship
Chief Financial Officer
Address
C/O RELAY THERAPEUTICS, INC., 60 HAMPSHIRE STREET, CAMBRIDGE
Signature
/s/ Soo-Yeun Lim, as Attorney-in-Fact
Signature date
30 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RLAY transaction

Common Stock

Sale

Transaction value
-$27,353
Shares
-1,469
Change %
-1.4%
Price
$18.62
Shares after
103,665
Date
28 Oct 2026
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 3,269 shares of restricted stock units ("RSUs") on October 27, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

Footnote F2

Includes 3,269 shares underlying RSUs.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .